As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
I emailed 126,148 leads that were over five years old — 61 responded, and seven converted that same week. I’d say that’s worth being “annoying” to a few.
Anthropic, Block, and OpenAI are backing the Linux Foundation’s new Agentic AI Foundation, donating MCP, Goose, and AGENTS.md to standardize AI agents, boost interoperability, and curb proprietary fragmentation.